# GeneFormatics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/geneformatics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $41M
- Latest round: Series C (Oct 17, 2001)
- Investors on record: 11

## About

GeneFormatics Inc. is based in US and operates as a biotechnology company which focused on the research and commercialization of novel function prediction methods for the rapid identification of biologically relevant targets.

## Funding rounds

- Series C, Oct 17, 2001, $22M — Burrill & Company, OrbiMed Advisors, CDIB Capital Group, Mesa Verde Venture Partners, GeneChem, Aisling Capital, Merrill Lynch Ventures, Moss Forest Ventures, Bruker Corporation, Bruker BioSpin GmbH, TAKARA SHUZO CO.,LTD.
- Series B, Oct 5, 2000, $15M — Burrill & Company, OrbiMed Advisors, Mesa Verde Venture Partners, GeneChem, Aisling Capital, Merrill Lynch Ventures, Moss Forest Ventures
- Series A, Feb 24, 2000, $4M — Burrill & Company, Mesa Verde Venture Partners, Moss Forest Ventures

## Investors

- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series A, Series B, Series C
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series A, Series B, Series C
- Moss Forest Ventures — Series A, Series B, Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series B, Series C
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series B, Series C
- Merrill Lynch Ventures — Series B, Series C
- CDIB Capital Group (https://capitalatlas.ai/funds/cdib-capital-group) — Series C
- Bruker Corporation — Series C
- Bruker BioSpin GmbH — Series C
- TAKARA SHUZO CO.,LTD. — Series C